Update on immune checkpoint inhibitors in gynecological cancers

In recent years, progress in our understanding of immune-modulatory signaling pathways in immune cells and the tumor microenvironment (TME) has led to rejuvenated interest in cancer immunotherapy. In particular, immunotherapy targeting the immune checkpoint receptors such as cytotoxic T-lymphocyte-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Heong, Valerie, Ngoi, Natalie, Tan, David Shao Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323287/
https://www.ncbi.nlm.nih.gov/pubmed/28028993
http://dx.doi.org/10.3802/jgo.2017.28.e20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323287/
https://www.ncbi.nlm.nih.gov/pubmed/28028993
http://dx.doi.org/10.3802/jgo.2017.28.e20

Ejemplares similares